Comprehensive Overview of Immunopeptidomics: From Sample Preparation to Bioinformatic Analysis

Immunopeptidomics has rapidly emerged as an advanced analytical field focused on identifying and characterizing peptides presented by major histocompatibility complex (MHC) molecules. This approach holds significant promise in tumor immunotherapy, vaccine development, and autoimmune disease research.

What Is Immunopeptidomics and Why Is It Important?

Immunopeptidomics refers to a mass spectrometry-based omics strategy for profiling peptides (i.e., immunopeptides) presented on MHC molecules. These peptides provide an endogenous readout of intracellular protein degradation processes and constitute key determinants for T-cell recognition of aberrant cell states, such as malignancy or infection.

Although technically demanding, immunopeptidomics offers direct biological insight, enabling:

• Precise identification of candidate antigens for cancer vaccine design or personalized immunotherapy.

• Elucidation of mechanisms underlying tumor immune evasion.

• Monitoring of immunotherapeutic response and resistance development.

Sample Preparation: The First Step to Success

Sample preparation is a critical determinant of data quality in immunopeptidomics, as MHC-associated peptides are typically of extremely low abundance and susceptible to degradation. Robust and reproducible workflows are therefore essential for ensuring reliable downstream analyses.

1. Cell Lysis and MHC Immunoprecipitation

Immunoprecipitation (IP) using monoclonal antibodies against MHC class I or class II represents the standard enrichment strategy. Typical requirements include:

• High-input cell or tissue samples (>10^7 cells).

• Low-temperature handling to minimize protein degradation.

• Optimized lysis buffers to ensure efficient isolation of intact MHC complexes.

2. Peptide Release and Purification

Following immunoprecipitation, bound peptides require further isolation and cleanup. Commonly applied procedures include:

• Acid elution (e.g., 0.1% TFA) for peptide release.

• Enrichment using C18 solid-phase extraction to remove contaminants and higher-molecular-weight proteins.

• Lyophilization to facilitate subsequent LC-MS/MS sample loading.

Mass Spectrometry Analysis: The Core Technology for Mapping Antigenic Repertoires

Immunopeptides are typically short (8-14 amino acids) and lack canonical protease cleavage motifs, imposing stringent analytical demands on mass spectrometry.

1. Instrument Selection: High Resolution Is Key

High-resolution LC-MS/MS platforms such as Orbitrap Fusion Lumos or Exploris 480, in combination with nano-LC systems, are recommended to achieve high-sensitivity detection of low-abundance peptides.

 

2. Data Acquisition Modes: DDA vs. DIA

• Data-Dependent Acquisition (DDA): Well suited for neoantigen identification, with relatively straightforward data quality control.

• Data-Independent Acquisition (DIA): Enables reproducible quantitative analysis when applied with existing antigen or spectral libraries.

Data Analysis: From Peptides to Biological Interpretation

Comprehensive data analysis pipelines in immunopeptidomics combine proteomics search algorithms with specialized computational components tailored to MHC-binding characteristics.

1. Peptide Identification

Search engines such as PEAKS, MaxQuant, and MSFragger can be applied for no-enzyme database searches with the following key parameter considerations:

• Enzyme specificity set to “none”

• Inclusion of common modifications such as oxidation and deamidation

• Tight precursor and fragment mass tolerances (<10 ppm)

2. MHC Binding Prediction and Epitope Annotation

Identified peptides can be processed using computational tools such as NetMHCpan and MHCflurry to predict their binding affinity to specific HLA alleles. These predictions inform:

• Neoantigen discovery and prioritization

• Selection of vaccine candidate peptides

• Development of personalized immunotherapy strategies

3. Downstream Functional Annotation

Integration of annotation resources such as UniProt, Gene Ontology (GO), and KEGG enables functional assignment of parent proteins and pathway enrichment analysis, thereby providing biological context for antigen discovery.

Challenges and Future Trends

Despite rapid advances, immunopeptidomics continues to face methodological and biological challenges, including:

• Detection limits associated with low-abundance peptides.

• Extensive polymorphism and diversity of HLA alleles

• Cross-sample comparability across individual subjects

Future developments are expected to emphasize:

• Single-cell-level immunopeptidome profiling

• Multi-omics integration with spatial transcriptomics and immune repertoire sequencing

• AI-assisted antigen prediction and target prioritization

Immunopeptidomics is reshaping current understanding of antigen presentation and immune recognition. In this complex yet promising domain, high-quality data acquisition combined with rigorous bioinformatic analysis is indispensable. As a leading provider of mass spectrometry and proteomics services, MtoZ Biolabs has established a comprehensive immunopeptidomics platform covering the full workflow from sample preparation and MHC enrichment to mass spectrometry analysis and bioinformatic interpretation. We serve national major research projects and innovative biopharmaceutical enterprises, enabling efficient identification of immune-related targets and accelerating the development of vaccines and cell therapies.

MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.

Related Services

Immunopeptidomics Service